Where does Anaeropharma Science, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Anaeropharma Science, Inc. ranks #44,698 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Anaeropharma Science, Inc. hold?

Anaeropharma Science, Inc. holds 5 US utility patents granted between 2016 and 2021, spanning 7 technology areas.

What is Anaeropharma Science, Inc.'s Innovation Score?

Anaeropharma Science, Inc. has an Innovation Score of 24.1 out of 100 (14th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Anaeropharma Science, Inc.'s patent grant rate increasing or decreasing?

Anaeropharma Science, Inc.'s recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Anaeropharma Science, Inc.'s patents?

Anaeropharma Science, Inc.'s patents average 14.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Anaeropharma Science, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Anaeropharma Science, Inc.

Q: What technology areas does Anaeropharma Science, Inc. focus on?

Anaeropharma Science, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 5 patents, ranking #1,801 of 4,144 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, recorded in grant years 2016–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Anaeropharma ranks #44,698 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 7 technology areas.

#44,698
of 49,997 US assignees by volume: 14th percentile
by Innovation Score (24.1/100): 14.2
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R44698 · Foreign Corporation #44,698 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 5 grants
LOWER-Q #44,698/49,997
PHOTO-FINISH Amtek Semiconductor
CPC-NARROW C12N · 7 areas
INNOV-THIN 24.1/100
CLAIMS-RICH 14.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Amtek Semiconductor Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Anaeropharma’s 24.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (26%) Velocity 0.0 pts (0%) Breadth 9.4 pts (39%) Claim depth 8.5 pts (35%)

Qualcomm Incorporated · highest

85
Anaeropharma Science · this assignee

24
3D Lighting… · lowest

7

What this shows Anaeropharma's Innovation Score is 24.1/100 (14th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Anaeropharma?

Each dot is one of Anaeropharma’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Anaeropharma’s own 14.2 claims/patent is at or below the 17.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Anaeropharma vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Anaeropharma's grants concentrate

Anaeropharma Science, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). By volume, Anaeropharma sits between Amtek Semiconductor Co., Ltd. and Anchor Semiconductor, Inc..

Amtek Semiconduct…

5
Amundson Technolo…

5
Anapp

5
Anabio

5
Analog Modules

5
Anatomacl

5
Anchor Innovation…

5
Anchor Semiconduc…

5
Anaeropharma Scie… ◀

5

What this shows Anaeropharma holds 5 patents at rank #44,872, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Anaeropharma

By rank, the assignees closest to #44,872 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Anaeropharma's primary technology class.

Anaeropharma's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 14th percentile higher than 14% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Anaeropharma Science, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	20.0%
2017	1	20.0%
2019	1	20.0%
2020	1	20.0%
2021	1	20.0%

Which technologies does Anaeropharma Science, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

C07K - Peptides 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Anaeropharma Science, Inc.'s patent record in context - here's where to go next.

Anaeropharma Science, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #44,698 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Anaeropharma Science, Inc. against Amtek Semiconductor Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.